Second season results from the Phase 3 SMART trial were presented at the 9th RSVVW Conference and will be shared with the U.S ...

From early failures to prefusion F protein breakthroughs, RSV vaccine development has accelerated, reshaping prevention strategies for infants and older adults.

For a century and a half, the sharp end of a needle has been the price of admission for modern medicine. Generations of children and parents have been conditioned to […] ...

According to the CDC it’s been a rough cold and flu season, and it’s a long way from being over, but you can take steps to protect yourself ...

Century Therapeutics (IPSC) aims at a durable “once-and-done” Type 1 diabetes cure with hypoimmune iPSC beta cells; runway to ...

A peanut allergy is commonly lifelong, as this doctor knows first-hand. It’s important to normalise peanuts as a foodstuff to ...

Five poster presentations highlight clinical advancement of neffy , real-world usability and advantages of needle-free epinephrine ...

Foresee Pharma gets fourth positive recommendation from DSMB to continue the Casppian Ph3 study, for central precocious puberty: Taipei Friday, February 6, 2026, 18:00 Hrs [IST] F ...

The FDA cited concerns about human factors in the use of Aquestive Therapeutics’ Anaphylm sublingual film for anaphylaxis and other type 1 allergic reactions in its complete response letter to the ...

Since it was first detected in the U.S. in 2014, H5N1 avian influenza, commonly known as bird flu, has jumped from wild birds to farm animals and then to people, causing more than 70 human cases in ...

The Casppian study design included periodic evaluations and long-term safety monitoring for up to a total of 12 months following the first injection. -- There has been no safety concern with the use ...

Approval is based on the CLEVER and SMART Clinical Trial ResultsKIRKLAND, QC, Feb. 5, 2026 /CNW/ -- Merck (NYSE: MRK), known as MSD outside the United ...